Questions about our services? (USA) 877-735-3648 Outside the US: 001-610-642-6055

December 2016 Newsletter

Encouraging news for Type 1s interested in using a GLP 1 med with insulin

We've been seeing more and more research lately on the use of Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drugs as a treatment adjunct for Type 1, and the news from this latest study is encouraging.

By |2016-12-16T16:03:15-05:00December 16th, 2016|Categories: December 2016 Newsletter|1 Comment

All-star team collaborates on closed loop system

Guess who is working together to integrate their respective technologies into the International Diabetes Closed Loop (IDCL) trial, which is funded by the National Institutes of Health and slated to begin before year's end…!

By |2016-12-16T17:18:13-05:00December 16th, 2016|Categories: December 2016 Newsletter|2 Comments
Go to Top